DarioHealth (DRIO) Cash from Operations (2012 - 2026)

DarioHealth (DRIO) has reported Cash from Operations for 15 consecutive years, with -$6.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations fell 0.86% year-over-year to -$6.1 million; the trailing twelve-month figure through Jun 2026 stood at -$25.3 million (up 5.4% YoY), and the FY2025 full-year result was -$25.9 million, up 32.73% from the prior year.
• Cash from Operations eased to -$6.1 million in Q2 2026 per DRIO's latest filing, from -$6.0 million in the prior quarter.
• Across five years, Cash from Operations topped out at -$4.8 million in Q1 2023 and bottomed at -$18.1 million in Q1 2022.
• Historically, Cash from Operations has averaged -$8.6 million across 5 years, with a median of -$7.4 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Cash from Operations soared 73.71% in 2023, then sank 175.59% in 2024.
• Over 5 years, Cash from Operations stood at -$7.9 million in 2022, then gained by 7.56% to -$7.3 million in 2023, then grew by 8.3% to -$6.7 million in 2024, then increased by 12.55% to -$5.9 million in 2025, then slipped by 3.33% to -$6.1 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered -$6.1 million, -$6.0 million, and -$5.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.